Business Description
Zhejiang Shengda Bio-Pharm Co Ltd
ISIN : CNE100002W43
Share Class Description:
SHSE:603079: Class ATotal Employee Number:
1,083Compare
Compare
Traded in other countries / regions
603079.China Index Membership
SSE Composite Index IPO Date
2017-08-23Description
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid, and other vitamin products, nisin, natamycin, and sucrose fermentation products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.8 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.21 | |||||
Debt-to-EBITDA | 4.67 | |||||
Interest Coverage | 95.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.23 | |||||
Beneish M-Score | -2.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.1 | |||||
3-Year EBITDA Growth Rate | 12.6 | |||||
3-Year EPS without NRI Growth Rate | 72.9 | |||||
3-Year FCF Growth Rate | 33.5 | |||||
3-Year Book Growth Rate | 2.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.83 | |||||
9-Day RSI | 42.05 | |||||
14-Day RSI | 39.21 | |||||
3-1 Month Momentum % | -29.14 | |||||
6-1 Month Momentum % | -43.39 | |||||
12-1 Month Momentum % | -36.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.69 | |||||
Quick Ratio | 3.64 | |||||
Cash Ratio | 2.87 | |||||
Days Inventory | 121.95 | |||||
Days Sales Outstanding | 64.46 | |||||
Days Payable | 103.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.95 | |||||
Forward Dividend Yield % | 0.95 | |||||
5-Year Yield-on-Cost % | 0.93 | |||||
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -2.08 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 25.81 | |||||
Operating Margin % | 8.92 | |||||
Net Margin % | 6.46 | |||||
EBITDA Margin % | 8.64 | |||||
FCF Margin % | 1.68 | |||||
OCF Margin % | 18.88 | |||||
ROE % | 3.53 | |||||
ROA % | 2.56 | |||||
ROIC % | 4.66 | |||||
3-Year ROIIC % | 22.19 | |||||
ROC (Joel Greenblatt) % | 6.81 | |||||
ROCE % | 3.84 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.41 | |||||
PE Ratio without NRI | 32.49 | |||||
Shiller PE Ratio | 30.17 | |||||
PS Ratio | 2.33 | |||||
PB Ratio | 1.25 | |||||
Price-to-Tangible-Book | 1.46 | |||||
Price-to-Free-Cash-Flow | 118.67 | |||||
Price-to-Operating-Cash-Flow | 12.14 | |||||
EV-to-EBIT | 24.53 | |||||
EV-to-EBITDA | 24.53 | |||||
EV-to-Revenue | 2.12 | |||||
EV-to-FCF | 125.82 | |||||
Price-to-GF-Value | 0.73 | |||||
Price-to-Projected-FCF | 1.65 | |||||
Price-to-Graham-Number | 1.45 | |||||
| Price-to-Net-Current-Asset-Value | 5.1 | |||||
| Price-to-Net-Cash | 211.2 | |||||
Earnings Yield (Greenblatt) % | 4.08 | |||||
FCF Yield % | 0.7 | |||||
Forward Rate of Return (Yacktman) % | -9.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Shengda Bio-Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 830.527 | ||
| EPS (TTM) (Â¥) | 0.29 | ||
| Beta | 0.63 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 33.08 | ||
| 14-Day RSI | 39.21 | ||
| 14-Day ATR (Â¥) | 0.543919 | ||
| 20-Day SMA (Â¥) | 11.0945 | ||
| 12-1 Month Momentum % | -36.99 | ||
| 52-Week Range (Â¥) | 9.94 - 22 | ||
| Shares Outstanding (Mil) | 189.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Shengda Bio-Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Shengda Bio-Pharm Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.100000 Cash Dividend | 2026-07-01 | 11.32 (-1.99%) | ||
| 1.4:1 Stock Split | 2020-06-08 | 29.21 (-0.70%) | ||
| 1.4:1 Stock Split | 2018-06-08 | 24.31 (-2.52%) |
Show
Entries
Zhejiang Shengda Bio-Pharm Co Ltd Frequently Asked Questions
What is Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079)'s stock price today?
The current price of SHSE:603079 is ¥10.56. The 52 week high of SHSE:603079 is ¥22.00 and 52 week low is ¥9.94.
When is next earnings date of Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079)?
The next earnings date of Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079) is .
Does Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079) is 0.95% (As of Today), Highest Dividend Payout Ratio of Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079) was 2.33. The lowest was 0.07. And the median was 0.44. The  Forward Dividend Yield % of Zhejiang Shengda Bio-Pharm Co Ltd(SHSE:603079) is 0.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zhejiang Shengda Bio-Pharm Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers